Pacientes y visitantes de Renown Health

SALA DE PRENSA DE RENOWN

Últimos comunicados de prensa

Noticias destacadas

Carreras profesionales

Awards & Accreditations

University of Nevada, Reno

Fundación de Renown Health



Recursos de medios

Renown Public Relations Media Icon
Renown Health's Public Relations Team
news@renown.org

Renown Health's public relations team supports media partners in finding experts on diverse health care topics. In addition, we provide information and answer all questions regarding Renown. We look forward to working with you.

Read MoreMedia Resources
  • Medios en el campus

    A los fines de la confidencialidad del paciente, las políticas de Renown Health requieren que los medios de comunicación estén acompañados por el personal de Relaciones Públicas en todo momento.

    El personal de Relaciones Públicas se complacerá en hacer los arreglos necesarios para el estacionamiento, notificará al personal del hospital correspondiente y lo ayudará a encontrar su destino.

     

    Presentaciones/transmisiones en vivo

    Los medios de comunicación pueden realizar reuniones presenciales y transmisiones en vivo en nuestros campus. A fin de proteger la confidencialidad del paciente y la fluidez del paso, un miembro del personal lo ayudará a encontrar la mejor ubicación para su historia.

    Le pedimos que respete nuestra obligación de proteger el bienestar de nuestros pacientes y el derecho legal a la privacidad.

  • Consultas sobre el estado del paciente

    Cumplimos con las reglamentaciones de la Ley de Portabilidad y Responsabilidad de Seguros de Salud de 1996 (Health Insurance Portability and Accountability Act, HIPAA) para todos los pacientes, incluidos los pacientes de interés público. Las reglamentaciones de la HIPAA especifican qué información puede y no puede divulgarse sin la autorización de un paciente.

    Las reglamentaciones de privacidad del paciente solo nos permiten compartir información relacionada con el estado de aquellos pacientes que figuran en nuestro directorio.

    Las consultas de los medios de comunicación requieren que se escriba correctamente el nombre y el apellido del paciente.

     

    Definiciones de “estado” utilizadas por Renown Health

    Al describir el estado de un paciente, solo podemos divulgar los siguientes estados de pacientes:

    Bueno: los signos vitales, como el pulso, la temperatura y la presión arterial, se mantienen estables y dentro de los límites normales. El paciente está consciente, cómodo y no presenta complicaciones.

    Regular: los signos vitales se mantienen estables y dentro de los límites normales. El paciente está consciente y alerta, aunque puede sentirse incómodo o adolorido, y puede tener complicaciones menores.

    Grave: los signos vitales pueden ser inestables o estar fuera de los límites normales. El paciente está gravemente enfermo o lesionado y puede tener complicaciones importantes.

    Crítico: los signos vitales son inestables o están fuera de los límites normales. Existen complicaciones importantes.

    Nota: “Estable” no es un estado.

Comunicados de prensa

Número de resultados encontrados: 17
Use esta navegación adicional para ir a las páginas siguientes. Use las teclas de tabulación e Intro para navegar por el menú1 Página n.º 2 Navegar a la página siguiente Página 1 de 2
Saltee a 17 resultados encontrados. Página 1 de 2
    • Miércoles, 06 de marzo de 2024

    Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

    Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. Acerca de Helix Helix es la compañía líder en genómica y vigilancia viral de la población cuyas operaciones se basan en el cuidado clínico, la investigación y el análisis de datos. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

    Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

    • Lunes, 29 de enero de 2024

    Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

    Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

    Read More About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

    • Miércoles, 22 de noviembre de 2023

    Three More Renown Urgent Cares Now Accepting Patients with Medicaid for a Total of Six Locations Across Northern Nevada

    Renown Health now offers urgent care services to patients with Medicaid insurance at the locations on USA Parkway, Los Altos and in Carson City.  Renown’s 10 Urgent Care locations see patients 365 days a year for medical concerns that are urgent but not life-threatening. Renown has recently expanded the number of urgent care sites accepting Medicaid insurance to include the USA Parkway, Los Altos and Carson City locations. Medicaid provides health coverage to thousands of Nevadans, including eligible low-income adults, children, pregnant women, elderly adults, and people with disabilities. Medicaid is now accepted at six Renown Health Urgent Care locations at the following addresses: 440 NV-439 #1, USA Parkway 202 Los Altos Pkwy, Sparks 2814 N. Carson St., Ste 101, Carson City 975 Ryland St., Reno 1343 W. Newlands Dr., Fernley 560 E. Williams Ave., Fallon “As Reno’s only not-for-profit health care provider, we see all patients, regardless of their ability to pay. Increasing access to urgent care medical services remains a priority for us,” said Brian Erling, MD, MBA, Renown Health President, and CEO. “With a lack of medical providers and long wait lists for care in Washoe County, many people may not seek treatment when ill, and their conditions become more advanced, making treatment more difficult and costlier. We are working to hire additional physicians and medical providers to meet the need. We are pleased to help reduce barriers to care by accepting people with Medicaid insurance at six urgent care locations in Reno-Sparks and in our neighboring communities.” Government initiatives like Medicaid are designed to help uninsured individuals secure health care coverage. Medicaid is the largest health insurance provider in the United States, providing coverage to millions of Americans. As of July 2023, 835,888 Nevadans have enrolled in Medicaid and CHIP (Children’s Health Insurance Program). Statistics show that 21% of people in Washoe County have Medicaid coverage (2021). “We continue to seek new ways to meet the healthcare needs of everyone in our community,” said Rahul Mediwala, MD, CPE, Renown Medical Group CEO. “Our skilled providers at all Renown Urgent Care locations are able to diagnose and treat a variety of non-life-threatening illnesses, including respiratory illness; allergic reactions; minor burns, cuts and bites; sprains; urinary tract infections and more.” For life-threatening emergencies and when urgent care locations are closed, the Emergency Rooms at Renown Regional Medical Center, Renown South Meadows Medical Center and Renown Children’s Hospital are ready to treat and care for all patients, 24/7. The current hours of operation for all Renown Health locations are available at renown.org/locations. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health.

    Read More About Three More Renown Urgent Cares Now Accepting Patients with Medicaid for a Total of Six Locations Across Northern Nevada

    • Miércoles, 01 de noviembre de 2023

    $5 Million Donation to Renown Health Foundation Will Increase Access to Breast Cancer Care in Northern Nevada

    Gift from Jeanne and Raymond Conrad will support development of the Conrad Breast Center in the new Specialty Care Center at Renown South Meadows Medical Center. Renown Health Foundation announced a $5 million gift from local philanthropists Jeanne and Raymond Conrad on Monday, Oct 30. This gift will establish the Conrad Breast Center at the William N. Pennington Cancer Institute at Renown. The center will be housed in the Specialty Care Center at Renown South Meadows Medical Center. The three-story, 121,000 square foot Specialty Care Center being built on the Renown South Meadows Medical Center campus will feature expanded laboratory and diagnostic services, a surgery center and expanded sterile processing department and more. The Conrad Breast Center is the latest addition to the services planned for the Specialty Care Center and will include imaging, infusion and surgery services along with a wellness center. “With a service area of over 100,000 square miles that serves approximately one million people, Renown sees individuals from all walks of life,” said Jeanne Conrad, philanthropist. “My husband Raymond and I share Renown’s vision for a healthy community and establishing advanced care options for even the most difficult-to-treat cancer cases. We all have been impacted by breast cancer in some way which is why we feel honored to create this legacy.” According to the National Cancer Institute, 12.9% of women born in the United States will develop breast cancer at some time during their lives (based on 2015–2017 data). Here in Nevada, the American Cancer Society estimates 2,620 new cases of breast cancer will be diagnosed in 2023 and that 440 Nevadans will die from breast cancer this year. “Renown Health’s mission to provide best-in-class care in our northern Nevada community and beyond is only possible with generous donors like Jeanne and Raymond Conrad,” said Brian Erling, MD, MBA, Renown Health President & CEO. “This gift establishing the Conrad Breast Center within the William N. Pennington Cancer Institute will positively impact lives in our community for years to come. Cancer does not discriminate and Renown strives to create care environments that cater to all individuals. Our goal is to save lives and ensure better outcomes while keeping families together with convenient care options.” During the formal announcement of the Conrad Breast Center on Monday, Oct. 30, Renown patient and breast cancer survivor, Carolyn Dragics, spoke about her experience receiving care at Renown. Carolyn emphasized that staying close to home was a crucial part of her care journey. To continue expanding regional cancer care options and keep locals close to home, Renown Medical Group recently welcomed two distinguished breast surgical oncologists, Colleen O'Kelly Priddy, MD and Michelle K. Chu, MD to the team. As part of this expansion, Renown is assuming operations of Reno Surgical Advocates, a respected private practice in Reno. “Northern Nevada’s population continues to grow, and Renown is positioning itself to have the appropriate amount of cancer care providers available for everyone who may need it,” said Greg Walaitis, Renown Health Chief Development Officer. “As the region’s largest not-for-profit healthcare system, Renown works tirelessly to provide members of our community with advanced care. This establishing donation from the Conrad family will continue to build Renown’s vision for increasing cancer care options in our region.” “Every day I am inspired by not only the patients we care for who are fighting the good fight against cancer, but also by the donors like the Conrad family who have given us the opportunity to support our patients in their fight,” said Max Coppes, MD, PhD, MBA, Renown Health’s William N. Pennington Cancer Institute Director. The Conrad Breast Center is another step towards the William N. Pennington Cancer Institute’s ultimate goal for our community: establishing an NCI-designated Cancer Center in Reno. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health.

    Read More About $5 Million Donation to Renown Health Foundation Will Increase Access to Breast Cancer Care in Northern Nevada

    • Miércoles, 04 de octubre de 2023

    Saving More Lives; Renown Expands Breast Cancer Care, Adding Two Best-In-Class Breast Surgeons

    Renown Medical Group is thrilled to welcome two distinguished breast surgical oncologists, Colleen O'Kelly Priddy, MD and Michelle K. Chu, MD to the team. These highly skilled breast surgeons will solely focus on providing breast care and therefore play a pivotal role in Renown Health’s William N. Pennington Cancer Institute’s commitment to provide subspecialized care to the people living in our community and beyond. Dr. Colleen O'Kelly Priddy is a fellowship-trained, board-certified breast surgical oncologist with an impressive background in breast cancer surgery. Dr. Priddy was born at Washoe Medical Center (which later became Renown Regional Medical Center) and grew up in Susanville, CA before attending Stanford University for her undergraduate studies. She is a graduate of the University of Nevada, Reno School of Medicine. "I am thrilled to return to Reno to help increase access to world-class surgical breast cancer care,” said Dr. Priddy. “My focus is to provide exceptional care, particularly for young people with breast cancer. I am excited to continue my mission here in northern Nevada." Dr. Michelle K. Chu, a board-certified general surgeon, brings her extensive experience in advanced breast cancer treatment to the Renown team. Dr. Chu received her undergraduate degree from the University of Pennsylvania and her medical degree from Western Reserve School of Medicine in Cleveland, OH. Dr. Chu specializes in oncoplastic breast conserving surgery and nipple sparing mastectomies. "I believe in tailoring treatment options to each patient's unique needs,” Dr. Chu said. “Whether it's preserving the natural shape of the breast or supporting the 'Going Flat' movement, our team strives to provide the best possible outcome for every patient." The newest addition to the William N. Pennington Cancer Institute, Renown Breast Surgery Care provides comprehensive breast surgery care at 1500 E. 2nd Street in Reno, adjacent to the Renown Regional Medical Center campus. "Breast cancer accounts for approximately 20% of newly diagnosed cancer cases in Washoe County, with roughly 520 new cases annually, establishing it as the most prevalent cancer type within our community,” says Brian Erling, MD, MBA, President & CEO, Renown Health. “We are proud, as the community’s largest not-for-profit healthcare system, to invest in cancer prevention and early diagnoses, including mammography screening and genetic research. For those diagnosed with breast cancer, Renown now offers two superb breast surgeons specializing in breast preservation surgery, and a breast surgery center providing comprehensive, compassionate care. Our goal is to save women’s lives, save families and ensure better care and better outcomes. This is a major step forward for women’s healthcare and our community.” As part of this expansion, Renown is assuming operations of Reno Surgical Advocates, a respected private practice in Reno. "Access to expert breast cancer care close to home is crucial, and our dedicated team at Renown Breast Surgery Care will work tirelessly to provide the highest level of care to patients while working closely with our other cancer specialists," said Max Coppes, MD, PhD, MBA, Director, William N. Pennington Institute for Cancer. “With the exceptional expertise of Dr. Colleen O'Kelly Priddy and Dr. Michelle K. Chu, coupled with our state-of-the-art facility; Renown Health is a true partner in the fight against breast cancer in northern Nevada.” "People are increasingly relocating to northern Nevada, and in fact, Washoe County experienced a 2.1% population growth from April 2020 to July 2022. Consequently, although northern Nevada does not exhibit an above-average cancer rate, we are observing a rise in cases at our facilities," said Dr. Lee Schwartzberg, MD, FACP, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute. "Renown Health is positioned to meet this growing demand, and we take pride in consistently adding nationally renowned healthcare providers to our team to save the lives of women in northern Nevada. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health.

    Read More About Saving More Lives; Renown Expands Breast Cancer Care, Adding Two Best-In-Class Breast Surgeons

    • Viernes, 24 de marzo de 2023

    Freenome Adds Renown Health As Partner for The Sanderson Study

    Freenome, a privately held biotech company announced today that Renown Health has joined as a partner for the Sanderson Study, Freenome’s study of its multiomics platform, in combination with real-world data to detect multiple cancers. The study encompasses both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition, the Sanderson Study will build the necessary infrastructure to bridge the gap between clinical research and day-to-day clinical impact. Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to detect cancer in its earliest stages using a standard blood draw. “We are delighted to partner with Freenome to launch this far-reaching trial which has transformative potential,” said Lee Schwartzberg, MD, medical oncology section chief and the principal investigator for the Sanderson Study at Renown. “Studying the impact of merging real-world information from patients with multiomics technology holds the promise of a truly personalized approach to early detection of cancer.” Renown Health has multiple clinical trials currently available to patients in northern Nevada across a variety of specialties, including oncology, cardiology, neurology, pediatrics, and pulmonology. Cancer is the second-leading cause of death in the Silver State, claiming the lives of more than 5,400 Nevadans each year. This number has increased since the last five-year plan estimates of 4,400 deaths per year.1 Promoting research to improve cancer prevention, detection, diagnosis and treatment is a key goal outlined in the Nevada Cancer Plan, 2021-2025, a framework developed by the Nevada Cancer Coalition in partnership with the Nevada Department of Health and Human Services. Access and participation in clinical trials is a key component of the plan, which, Renown says, makes participation in the Sanderson Study even more significant. “At the inception of the William N. Pennington Cancer Institute, we committed to not only provide the very best care possible to our community, but to also help improve outcomes through participation in research,” said Max Coppes, MD, PhD, MBA, cancer center director of the William N. Pennington Cancer Institute. “The research collaboration with Freenome has the potential to make a dream come true: Finding cancer early when it’s most treatable.” The Sanderson Study will enroll approximately 8,000 patients through Freenome’s clinical study partner network and numerous regional health systems across the United States. “Renown is committed to making a difference in the health and well-being of patients in communities across the state of Nevada, and that includes access to innovative research,” said Lance Baldo, MD, chief medical officer at Freenome. “The combination of real-world data and multiomics is poised to transform the landscape of early cancer detection.” Freenome’s clinical studies are named for employees’ loved ones who fought cancer. This study honors Tim Sanderson, the loving father of a Freenome engineer. For residents of Nevada interested in participating in the Sanderson Study, contact the William N. Pennington Cancer Institute clinical research coordinators at renown-crd@renown.org. Click here for more information on the Sanderson Study. About Freenome Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California. About Renown Health’s William N. Pennington Cancer Institute The William N. Pennington Cancer Research Institute provides comprehensive multidisciplinary cancer care for the northern Nevada community, helps educate the next generation of healthcare providers, and works to improve treatments and outcomes through active participation in research. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health.

    Read More About Freenome Adds Renown Health As Partner for The Sanderson Study

    • Lunes, 23 de enero de 2023

    Dr. Lee Schwartzberg Honored With 2023 Legends in Cancer Award

    Recognized as one of the world’s leading breast cancer experts as a 2023 Legends in Cancer Honoree Dr. Lee Schwartzberg, FACP, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute at Renown, was honored as the 2023 Legends in Cancer honoree at this year's Best of Breast conference for his contributions to the field of breast cancer. The conference took place on Jan. 21 and 22. Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 36 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates across the country, and here in Washoe County have declined progressively due to advancements in treatment, detection, and care. Each year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 in men. Here in Washoe County, more than 21 deaths per 100,000 females are due to breast cancer, a significant decrease since 2012 when 24 deaths per 100,000 females were reported. Dr. Schwartzberg was selected for this award based on his unique and vast contributions to advancing science and patient care, including his major research interests such as therapeutic approaches to breast cancer, targeted therapies, and supportive care. The selection committee evaluates each candidates’ body of work — including contributions to the field of breast cancer in clinical research, patient care, mentoring and community service — before deciding on an honoree. “Dr. Schwartzberg is deserving of this honor. As a national expert in the study and treatment of breast cancer, precision medicine and supportive care, Dr. Schwartzberg is transforming cancer care and improving the lives of all of us in northern Nevada. As the most preferred cancer program in the region, we are working with the support of donors like The William N. Pennington Foundation to recruit additional oncology specialists and cancer science researchers to become the first National Cancer Institute-designated comprehensive cancer care center in Nevada," said Dr. Brian Erling, MBA, CEO of Renown Health. “The incredible care that comes from the William N. Pennington Cancer Institute is possible because of nationally recognized oncologists like Dr. Schwartzberg.” “Dr. Schwartzberg completed fellowship training in medical oncology and hematology at Memorial Sloan Kettering Cancer Center in New York, where he also served as Chief Medical Resident and was a founding member of the institutional ethics committee,” add Paul J. Hauptman, MD, dean of the University of Nevada, Reno School of Medicine and chief academic officer for Renown Health. “We are proud that he serves as a professor of clinical medicine at the University of Nevada, Reno School of Medicine. His research interests include supportive care, precision medicine and patient-reported outcomes in breast cancer and he has published over 300 peer-reviewed manuscripts, book chapters and monographs.” “It is an honor to work with Dr. Schwartzberg and his patients have the most incredible things to say about the care he provides.” said Dr. Max J Coppes, PhD, MBA, Director, William N. Pennington Cancer Institute, Renown Health. “He understands that his patients are going through one of the most challenging times in their lives. Dr. Schwartzberg brings decades of experience to our community, is a great listener, and treats everyone with compassion and dignity. We are so proud to have him at Renown.” The Best of Breast Conference is an innovative medical education program that gathers the world's leading breast cancer experts to discuss cases with high-risk characteristics, adjuvant and metastatic treatment advances, interdisciplinary care and survivorship and recurrence — all while incorporating data from the major oncologic annual meetings. Dr. Schwartzberg has been selected to chair Total Health’s spring oncology education retreat in Lake Tahoe on April 15 and 16. The event’s comprehensive agenda will allow attendees to engage with the latest research and strategies in cancer care while networking with colleagues from across the country in a peaceful setting. Additional conference information is available here. Se recomienda que las mujeres se realicen exámenes con mamografía después de los 40 años. For those age 75 and older, a mammogram is recommended every year. Having regular mammograms can lower the risk of dying from breast cancer. Both 3-D digital mammography and whole breast ultrasounds are available at the Greenberg Breast Health Center at Renown and other locations across northern Nevada. The Affordable Care Act makes breast cancer screening and counseling free. All health plans must cover these benefits at no cost to you. Renown MyChart app users can self-schedule a mammogram appointment. To call to schedule, dial 775-982-8100. At the William N. Pennington Cancer Institute at Renown Health, patients receive innovative, personalized treatment to fight cancer while an experienced team provides the support and technology to maintain the highest quality of life. The Renown team’s clinical expertise and advanced treatment options blend evidence-based care with leading-edge research to improve cancer outcomes for every patient and family. For more information or a referral, visit renown.org/cancer. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. About Total Health Total Health is a medical information company of planning experts who produce tailored content, courses, and conferences for oncology healthcare providers, virtual and in-person. Total Health believes knowledge is power. Its mission is to give oncology healthcare providers an educational experience that equips them with the latest strategies to improve clinical practice and treatment outcomes.

    Read More About Dr. Lee Schwartzberg Honored With 2023 Legends in Cancer Award

    • Miércoles, 03 de agosto de 2022

    Dr. Max Coppes to Lead William N. Pennington Institute

    Max Coppes, M.D., Ph.D., MBA who has served as Nell J. Redfield Chair of Pediatrics at the University of Nevada School of Medicine (UNR Med) and pediatrician-in-chief at Renown Children’s Hospital for the last six years has announced he is stepping down to lead Renown’s Pennington Cancer Institute on a full-time basis. Dr. Coppes will continue to serve as Professor of Pediatrics and Internal Medicine at UNR Med. “Our goal is to improve the health of Nevadans and reduce the burden of cancer,” said Thomas Graf, CEO of Renown Health. “Having Dr. Coppes as our clinical leader for the William N. Pennington Cancer Institute on a full-time basis reflects Renown and UNR Med’s commitment to increase access to cancer care, foster a deeper partnership with UNR Med on clinical trials, collaborate on cancer research opportunities, and enhance medical education and post-graduate training. We are thrilled to have Dr. Max leading this important effort.” Today’s announcement comes two weeks after the William N. Pennington Foundation announced a $15.5 million gift to the Renown Health Foundation to help establish the William N. Pennington Cancer Institute at Renown. Dr. Coppes, a pediatric oncologist by training, has experience in leading large-scale, nationally recognized academic cancer center teams in both the U.S. and Canada. El Dr. Coppes llegó a Reno en 2014 procedente de la British Columbia Cancer Agency de Vancouver, donde ocupó el cargo de presidente responsable de seis centros oncológicos regionales y dos centros de investigación del cáncer. He was an attending physician at BC Children's Hospital and a professor of Medicine and Pediatrics at the University of British Columbia. During his career, Coppes served as senior vice president at Children's National Medical Center in Washington, D.C. and held positions at several prestigious facilities in the U.S. and Canada including The Hospital for Sick Children (SickKids) in Toronto, Georgetown University, The National Cancer Institute, and the Cleveland Clinic. Since 2016, Dr. Coppes has served in the joint leadership role as the Nell J. Redfield Chair of Pediatrics at UNR Med and pediatrician-in-chief at Renown Children's Hospital, a position made possible through generous philanthropic support from the Nell J. Redfield Foundation along with investments by Renown Health and the School of Medicine. In 2016, the Pennington Foundation recognized the need for enhanced care and expertise for pediatrics and donated $7.5 million to Renown Children’s Hospital to establish the William N. Pennington Fund for Advanced Pediatric Care. “As the Nell J. Redfield Chair of Pediatrics at the University of Nevada, Reno School of Medicine and pediatrician-in-chief at Renown Children's Hospital, Dr. Coppes blazed the trail for the integration of academic and clinical missions at UNR Med and Renown. He demonstrated visionary leadership and undoubtedly will bring the same energy and vision as the clinical leader for the William N. Pennington Cancer Institute,” said Melissa Piasecki, Acting Dean of UNR Med and Chief Academic Officer for Renown Health. “Dr. Max Coppes is an extraordinary leader. In the last six years he has done much to elevate the standard of pediatric care available in our community,” said Sy Johnson, President and Chief of Staff of Renown. “Thanks to Dr. Coppes’ leadership, the generosity of the Pennington gift and other donors, 100,000 area children now have access to pediatric specialists and contemporary healthcare services at the region’s only children’s hospital. Now, less than 3% of all pediatric patients and their families need to leave the area for specialty care. That is an incredible accomplishment.” Significant achievements made under Dr. Coppes leadership include: Advancing Renown Children’s Hospital, the only dedicated children’s hospital in northern Nevada, offering programs and services for families from a 100,000 square mile area, from Sacramento, CA to Salt Lake City, Utah. Renown Children’s provides the area’s only Children’s Emergency Room, Pediatric ICU (PICU), children’s imaging center and the largest neonatal ICU (NICU), a level III intensive care unit. Under his leadership, the following service lines were established; adolescent medicine, pediatric hematology/oncology, pediatric nephrology, pediatric infectious diseases, pediatric ophthalmology, pediatric orthopedic surgery, pediatric cleft and craniofacial surgery, pediatric urology, pediatric dentistry, and pediatric emergency medicine. Hiring and supporting a team of over 40 pediatric physician specialists. These clinicians provide 30,000 patient visits annually, offering an exceptional level of care to help families. As a testimony to the community’s confidence in the care provided, market share for pediatric services at Renown Health is now close to 90%. Renown’s membership in the Children’s Oncology Group (COG), which gives local pediatric cancer patients access to the world’s largest organization devoted exclusively to childhood cancer and most leading-edge treatments. Application to establish a 3-year accredited (by the Accreditation Council for Graduate Medical Education (ACGME) pediatric residency program in Reno. If approved in September 2022, Renown Health and UNR Med will start training four new pediatricians each year starting in July 2023. Successful application to the Nevada Governor's Office of Science, Innovation & Technology to receive financial support to fund a new Graduate Medical Education program. Renown Children’s Hospital was awarded $ 870,433 for the new pediatric residency program. New construction of an expanded Neonatal Intensive Care Unit (NICU) with increased capacity to 49 bassinets, an expanded Pediatric Intensive Care Unit (PICU) with increased capacity to 16 private patient and family rooms, and a new Renown Children's Hospital in-patient floor with increased capacity for 38 private patient and family rooms for a total capacity of 58 pediatric beds on Level 4 of Renown Regional Medical Center. In 2021, Dr. Coppes was named the Healthcare Hero Community Partner by Northern Nevada Business Magazine.

    Read More About Dr. Max Coppes to Lead William N. Pennington Institute

    • Miércoles, 13 de julio de 2022

    Lucha por una causa justa: Pennington Foundation Donates 15.5 Million Dollar Grant to Transform Cancer Care in Northern Nevada

    Generous gift will establish the William N. Pennington Cancer Institute at Renown Health. The William N. Pennington Foundation has announced a $15.5 million gift to the Renown Health Foundation to help establish the William N. Pennington Cancer Institute at Renown. This gift will help to bolster care and clinical expertise to improve the lives of people with cancer across northern Nevada. This is the largest gift Renown has ever received. This is the second major donation Renown Health has received from The William N. Pennington Foundation. In 2016, the Pennington Foundation recognized the need for enhanced care and expertise for pediatrics and donated $7.5 million to Renown Children’s Hospital to establish the William N. Pennington Fund for Advanced Pediatric Care. Through this gift, 100,000 area children now have access to pediatric specialists and contemporary healthcare services at the region’s only children’s hospital. Prior to 2016, about 30 percent of all pediatric patients had to leave northern Nevada to receive the specialty care they needed. Now, thanks to the Pennington Foundation’s support, Renown estimates that 97% of all pediatric patients and their families can receive both general and specialty pediatric care locally. Now, improving access to cancer care services in northern Nevada is the priority. According to the National Cancer Institute, approximately 39.5% Americans will be diagnosed with cancer at some point during their lifetimes (based on 2015–2017 data). Here in Nevada, the American Cancer Society estimates 16,390 new cases of cancer will be diagnosed in 2022 and that 5,730 Nevadans will die from cancer this year. The most frequent cancers seen include breast, prostate, lung and colo-rectal cancers. “The Pennington Foundation gift is so appreciated, as it honors a man who had a passion for improving lives and provides a legacy for the our current generation,” said Thomas R. Graf, M.D., FAAFP, Chief Executive Officer of Renown Health. Dr Graf also serves as Chief Clinical and Quality Officer at Renown, and Senior Associate Dean for Clinical Affairs for University of Nevada, Reno School of Medicine. “Estamos profundamente agradecidos por esta donación transformadora. This gift will allow Renown to continue our mission of making a genuine difference in the health and well-being of people with cancer- their families, and the communities we serve.” The Renown Institute for Cancer will now be named the William N. Pennington Cancer Institute in honor of the man who was a gaming pioneer, businessperson, and philanthropist. In former publications, the late philanthropist, Bill Pennington said, “During my many years in business, I was fortunate to work with thousands of wonderful employees, all of them Nevadans. Their efforts helped create the William N. Pennington Foundation, and I hope the Foundation will, in turn, help future generations of Nevadans for many years to come.” The Pennington grant will focus on bolstering expert clinical care to address the many concerns that come with a cancer diagnosis and allow people to stay in northern Nevada instead of having travel hundreds of miles out of the area for specialty care. The Institute will be devoted to advancing cancer care, cancer screening, prevention, and cancer research, including the ability to offer the latest clinical trials. “Our goal is to offer our community comprehensive clinical services, basic, translational and clinical research, medical education to students and post-graduate training, and population health with community outreach to reduce the burden of cancer. Ultimately, the vision is to become accredited by the National Cancer Institute,” said Max J. Coppes, MD, PhD, MBA, Cancer Center Director. “We are incredibly thankful and grateful for the commitment and support of the William N. Pennington Foundation,” said Greg Walaitis, Renown Health Foundation’s Chief Development Officer. “We appreciate the Pennington Foundation’s belief in Renown’s charitable mission to build a healthier community, together. We thank them for Joining the Good Fight.”   Renown Health is the region’s largest locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The University of Nevada, Reno School of Medicine (UNR Med) and Renown Health affiliated in June of 2021 to establish Nevada’s first integrated health system with missions in education, patient care, and clinical research. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Visite renown.org para obtener más información.

    Read More About Joining the Good Fight: Pennington Foundation Donates 15.5 Million Dollar Grant to Transform Cancer Care in Northern Nevada

    • Miércoles, 05 de enero de 2022

    Renown Children’s Hospital se une a Children’s Oncology Group

    Dr. J. Martin Johnston, Renown Health's Chief of Hematology and Oncology. Renown now home to northern Nevada's only Children's Oncology Group institution, giving local pediatric cancer patients access to the most cutting-edge treatments. Renown Children's Hospital announced today that it is now a member of the Children's Oncology Group (COG), the world's largest organization devoted exclusively to childhood cancer. Membership in the COG allows Renown to enroll its youngest patients in the latest clinical trials, including ground-breaking treatments for many childhood cancers, studies to better understand these diseases, and trials focused around supportive care and survivorship. Renown is now enrolling pediatric patients in clinical trials through the COG. Through this process, many childhood cancer patients will be eligible to receive newly-developed therapies.  For example, some trials employ immunotherapeutic drugs in addition to conventional chemotherapy, in hopes that adding the immunotherapy results in better health outcomes for pediatric cancer patients. "As a pediatric intensivist by training, I understand how quickly advancements are made in pediatric medicine," said Tony Slonim, MD, DrPH, President & CEO of Renown Health. "As a member of the COG, pediatric oncology patients of Renown Children's Hospital now have access to the latest and most cutting-edge treatment options in addition to commonly prescribed treatments. I am proud of the highly-skilled caregivers at Renown who are constantly expanding their knowledge and contributing research to give our pediatric patients and their families hope for the future." "Until now, we have been able to offer treatments at Renown based on the current standard of care, which means the treatment is based on published trial results that may not reflect the latest research in the field," said Renown's Chief of Hematology/Oncology, J. Martin Johnston, MD. "Previously, a pediatric oncology patient could only enroll in a COG trial if the family had the capacity to temporarily relocate to the Bay Area or Salt Lake City, for example. Now, our patients will have the opportunity to enroll in these trials without the need to travel so far from home." "When faced with pediatric cancer, the last thing parents should worry about is traveling great lengths to receive the best in cancer care," said Larry Duncan, Vice President of Pediatrics and Surgery and Administrator, Renown Children's. "We are proud to now offer the most advanced childhood cancer treatment options here at Renown, close to home and convenient for area patients and their families. We always strive to see more patients beat cancer, and being part of the COG helps our expert team of pediatric oncologists implement innovative and new ways to make that happen." Austin, el hijo de Brenda Milligan, residente de Carson City, tenía 5 años cuando le diagnosticaron leucemia y recibió tratamiento en el Renown Children’s Hospital. As an active participant in her now 10-year-old son's treatment plan, Brenda shares that she regularly sought out advice from COG providers across the country and is pleased that northern Nevadan parents of children being treated for leukemia can now take full advantage of the COG right at home. "The COG allows Renown's providers to have access to treatment plans that weren't available when Austin was receiving treatment," said Brenda. "It comforts me to know that not only can children receive cancer treatment right at home, but their parents can now elect for them to participate in trials and plans that are at the forefront of cancer treatment today." Según el COG, más del 90 % de 14,000 niños y adolescentes estadounidenses con diagnóstico anual de cáncer reciben atención en instituciones miembro del COG. Como institución miembro del COG, Renown se une a más de 200 instituciones, entre ellas Stanford, UCSF y Kaiser Permanente, en este prestigioso honor. El COG está compuesto por más de 9,000 expertos en todo el mundo y tiene alrededor 100 de estudios clínicos traslacionales activos que se llevan a cabo de manera simultánea. Research from the COG has drastically transformed children's cancer outcomes. Hace solo 50 años, se pensaba que el cáncer pediátrico era intratable; mientras que hoy, tiene una tasa de supervivencia combinada a cinco años del 80 %. "The key to ending childhood cancer is through extensive scientific research and clinical trials," said Max Coppes, Cancer Center Director at Renown Institute for Cancer. "As a COG member institution, our doctors will have the opportunity to collaborate with other pediatric oncologists around the world who share a common goal—to cure all children of cancer. At Renown, we are proud to be at the forefront of life-saving research and treatments for pediatric oncology patients throughout our region." “También agradecemos a William N. Pennington Foundation por su apoyo para establecer el Fondo William N. Pennington para la atención pediátrica avanzada en 2016, que nos permitió contratar a más de 15 pediatras especializados, incluso en oncología/hematología, lo cual fue crucial para nuestra solicitud para la membresía del COG”. About Renown Children's Hospital Renown Children's Hospital is the only dedicated children's hospital in northern Nevada, and offers a variety of programs and services designed specifically to care for families in our community. It has the region's only pediatric ER and ICU. Renown Children's Hospital is not-for-profit and relies on philanthropic support. Visit renown.org/give to support Renown Children's Hospital. For more information on programs and services, visit renown.org/children.

    Read More About Renown Children’s Hospital Joins The Children’s Oncology Group

    • Lunes, 26 de julio de 2021

    El humo de los incendios forestales es más peligroso que cualquier otro tipo de contaminación atmosférica para las personas con asma

    El Índice de calidad del aire de fase 2 y los alarmantes estudios de investigación del DRI, Renown Health y el Distrito de Salud del Condado de Washoe conducen a un aviso de salud pública; se debe buscar atención médica si es necesario. Para las personas que padecen asma, el humo de los incendios forestales es más peligroso que cualquier otro tipo de contaminación atmosférica, según un estudio del Desert Research Institute (DRI), el Renown Institute for Health Innovation (Renown IHI) y el Distrito de Salud del Condado de Washoe (WCHD). El estudio publicado en la revista Environmental Health examinó las asociaciones entre las partículas en el aire (particulate matter, PM) procedentes de fuentes como los incendios forestales, el transporte y la industria, y las visitas médicas por asma en los departamentos de emergencia y centros de Urgent Care de Renown Health en Reno, Nevada, durante el período de seis años comprendido entre 2013 y 2018. In places like Reno, where wildfire events occur regularly during parts of the year and are expected to become more frequent in the future, an accurate understanding of the impacts of wildfire smoke on population health is critical. We have an exceptional process in place through our urgent care sites, Renown Medical Group offices and hospital emergency departments to screen, diagnose and treat members of our community who come to us for care related to asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, and other upper respiratory diseases that may be exacerbated by wildfire smoke. At the same time, we continue to develop and refine, in real-time, the data that supports our predictive analytic models. We are using every tool and resource-including scientific data and clinical reporting, to ensure that we are meeting both the health and healthcare needs of the people we serve. En el estudio, los investigadores descubrieron que la calidad del aire en el área de Reno se vio afectada por el humo de los incendios forestales en un total de 188 días durante el periodo del estudio. En total, se produjeron 18,836 visitas a la sala de emergencias y atención de urgencia relacionadas con el asma durante el mismo período de cinco años, lo que indica que es importante comprender la influencia del humo de un incendio forestal y otros tipos de contaminación atmosférica en esta afección médica. La Air Quality Management Division (AQMD) del Distrito de Salud del condado de Washoe ha emitido una advertencia de contaminación del aire de fase 2 debido al humo de los incendios en el área. La calidad del aire en el área de Reno-Sparks ahora es “muy poco saludable” y tiene un Índice de calidad del aire de 247. La advertencia de fase 2 significa que todos los residentes deben permanecer en sus residencias y reducir los niveles de actividad debido a la susceptibilidad de mayores riesgos para la salud. To see current air quality in Reno-Sparks, click here. Brion Hill, MD who practices at the Renown Urgent Care - Los Altos location warns, “This is an important health advisory, exposure to elevated PM2.5 (fine particulate matter in smoke) concentrations can result in eye and throat irritation, headaches, nausea, shortness of breath, congestion, coughing, impaired lung function and chest pain. Everyone should take precautions when the air quality is unhealthy. Air pollution can aggravate heart and cardiovascular disease as well as lung diseases like asthma and COPD. When the air quality is unhealthy, people with these conditions may experience symptoms like chest pain, shortness of breath, wheezing, coughing, or fatigue. If you are experiencing any of these symptoms, use your inhalers as directed and contact your health care provider,” says Dr. Hill. “Si no tiene un proveedor de atención médica, tenemos 11 consultorios de Renown Urgent Care convenientemente ubicados con proveedores listos para atenderlo los 7 días de la semana”. Dr. Joseph Grzymski, a research professor at Desert Research Institute, a corresponding author on the study and Chief Scientific Officer, Renown Health, says, “This air is very bad for your health. Given today’s Air Quality Index in Reno, being outside and breathing this air for a day equals about smoking half a package of cigarettes.” Información adicional: The full text of the article “Particulate matter and emergency visits for asthma: a time-series study of their association in the presence and absence of wildfire smoke in Reno, Nevada, 2013–2018” (Partículas en el aire y visitas de emergencia por asma: un estudio de series temporales de su asociación en presencia y ausencia de humo de incendios forestales en Reno, Nevada, entre  y ) está disponible en Environmental Health: https://ehjournal.biomedcentral.com/articles/10.1186/s12940-020-00646-2 Para obtener más información sobre el Renown Institute for Health Innovation, visite: https://www.dri.edu/renown-ihi/ Renown Urgent Care brinda tratamiento para una amplia gama de lesiones leves, enfermedades e inquietudes médicas que son urgentes, pero no suponen un riesgo para la vida y que requieren atención médica en el mismo día. También le evita los tiempos de espera prolongados y los altos precios de la sala de emergencias en los 13 centros convenientes, incluidas Reno, Sparks, Carson City, USA Parkway, Fallon y Fernley. You can walk-in or book ahead online. The Washoe County Health District offers online health information on its Be Smoke Smart website, including fire information, daily air quality information, fire and smoke maps and how to protect yourself.     About the Desert Research Institute The Desert Research Institute (DRI) is a recognized world leader in basic and applied interdisciplinary research. Committed to scientific excellence and integrity, DRI faculty, students, and staff have developed scientific knowledge and innovative technologies in research projects around the globe. Desde 1959, la investigación del DRI ha profundizado el conocimiento científico, ha apoyado la diversificación de la economía de Nevada, ha proporcionado oportunidades educativas científicas y ha informado a legisladores, líderes empresariales y miembros de la comunidad. With campuses in Reno and Las Vegas, DRI serves as the non-profit research arm of the Nevada System of Higher Education. Para obtener más información, visite www.dri.edu. Acerca de Renown Health Renown Health es una red de atención médica integrada de administración local y sin fines de lucro que brinda servicios al norte de Nevada, Lake Tahoe y el noreste de California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown tiene una larga trayectoria y un compromiso de larga data con la mejora de la atención y la salud de nuestra comunidad. Visite renown.org para obtener más información.

    Read More About Wildfire Smoke More Dangerous Than Other Air Pollution for People With Asthma

    • Viernes, 16 de julio de 2021

    ¿Tiene tos, secreción nasal, dolor de garganta y fiebre? It Might Be RSV Virus

    El equipo de Renown Urgent Care lo prepara para mantenerse alerta y seguro en esta temporada y está disponible para la asistencia médica los 7 días de la semana, en 11 ubicaciones en todo el norte de Nevada. In June, staffers at the Centers for Disease Control and Prevention sent a Health Advisory requesting that clinicians and caregivers watch for the respiratory syncytial virus, usually known as RSV, an infection that puts thousands of toddlers and senior citizens in the hospital each year with pneumonia and deep lung inflammation. Según los CDC, el VRS provoca aproximadamente 58,000 hospitalizaciones y entre 100 y 500 muertes cada año entre niños menores de cinco años, así como 177,000 hospitalizaciones y 14,000 muertes entre adultos mayores de 65 años. La agencia advirtió que el VRS estaba apareciendo en 13 estados del sur y el sureste, y que los médicos debían hacer pruebas para detectar el virus si los niños presentaban estornudos, sibilancias o poco apetito y la garganta inflamada. Usually a winter infection, RSV is usually gone by June. Instead, this year, it is spreading—and has since continued to spread across the country, and to northern Nevada. “Sabemos que muchos de los buenos hábitos de higiene que desarrollamos para defendernos de la COVID-19 alteraron el panorama viral en los últimos 16 meses, y suprimieron las infecciones de casi todos los patógenos. Now RSV’s out-of-season return tells us that we need to continue to be on the alert,” says Robert Thole, MD, a physician with Renown Urgent Care. “We are surprised to be seeing so many kids with RSV right now.” “We ask parents and caregivers to keep a watchful eye out for a respiratory syncytial virus (RSV) infection. Symptoms are usually mild and resemble those of the common cold. RSV infection sometimes leads to bronchiolitis, pneumonia, or both. Symptoms of these complications include; difficulty breathing; wheezing; coughing that is getting worse; lethargy, increased tiredness, decreased interest in surroundings, or loss of interest in food,” explains Dr. Thole, who is board certified in family medicine. Catching and spreading the virus People with RSV infection may spread the virus through their secretions (saliva or mucus) when they cough, sneeze, or talk. You can catch the virus by: Touching an object or surface contaminated with the virus and then touching your nose, eyes, or mouth without first washing your hands. El virus puede sobrevivir durante más de 6 horas en las encimeras y otras superficies firmes, como los picaportes, y durante 30 minutos en las manos, la ropa o el papel tisú. Close contact. If an infected person coughs or sneezes near you, you could breathe in RSV that is in his or her saliva or mucus. The virus spreads easily in crowded settings, such as childcare facilities, preschools, and nursing homes. Children attending school often spread the virus to their parents and siblings. El período de incubación (el tiempo que transcurre desde la exposición al VRS hasta que tiene síntomas) varía entre dos y 8 días, pero generalmente es de entre 4 y 6 días. Las personas tienen más probabilidades de contagiar el virus durante los primeros días tras el inicio de los síntomas de la infección por VRS y siguen contagiando durante 8 días. Los bebés y los niños pequeños pueden propagar el virus durante 3 o 4 semanas como mínimo. Most children and adults feel better after a week or two. Treatment For an otherwise healthy child who has symptoms of an upper respiratory infection, such as a cough or runny nose, home treatment usually is all that is needed. It is important to watch for signs of complications, such as dehydration. Watchful waiting may not be a good choice when your child with an upper respiratory infection has an increased risk for complications. Watch your child closely if there are symptoms of an upper respiratory infection. If symptoms get worse or new symptoms develop, see a doctor right away. There is no vaccine and few specific treatments aside from supportive care, such as administering pain relievers and fluids. In the most severe cases, some children or adults might need additional oxygen. Not just in kids, older adults at risk Dr. Thole explains, “RSC is not only seen in children. Los adultos mayores de 65 años tienen un mayor riesgo de complicaciones tras la infección por el VRS. Pneumonia is a particular risk, especially if other health problems exist, such as chronic obstructive pulmonary disease (COPD) or heart failure. It may take older adults longer to recover from RSV infection and its complications than people in other age groups.” Llame 911 a los servicios de emergencia de inmediato si ocurre alguna de las siguientes situaciones: Your child has severe trouble breathing. Your child's breathing has stopped. Start rescue breathing. Call your doctor now if your baby or child has moderate trouble breathing. Call a doctor if your child: Breathes slightly faster than normal and seems to be getting worse. La mayoría de los niños sanos respiran menos de 40 veces por minuto. Has cold symptoms that become severe. Has shallow coughing, which continues throughout the day and night. Has a poor appetite or is being less active than usual. Has any trouble breathing. Hospitalization Doctors sometimes give a monoclonal antibody treatment to high-risk babies throughout the respiratory season to prevent them from catching the virus or developing a severe infection. Some hospitals have started to increase use of the prophylaxis in response to the recent uptick in RSV cases. “Those kids were being protected,” said Kristina Deeter, MD who was quoted in a July 1st Wall St. Journal article on this topic. Dr. Deeter is a pediatric intensivist and medical director at Renown Children’s Hospital Pediatric Intensive Care and Hospitalist Medicine. Dr. Deeter, who also oversees Pediatrix Medical Group’s critical-care team in dozens of pediatric intensive care units across the country, said hospitals are also considering taking additional precautions in the neonatal intensive-care unit similar to some wintertime protocols. At Renown Children’s Hospital, there were no children hospitalized with RSV throughout the winter season, Dr. Deeter said, when there are normally hundreds of cases in our county- many of which do not need to be hospitalized.” Se ha informado un total de 31 casos en el condado de Washoe, Nevada, desde abril, y 26 de estos casos ocurrieron dentro de las últimas tres semanas. Preventing infection To prevent infection, or at least to mitigate them, wear masks, stay home when sick, and washing hands could make a difference in how the next viral season unfolds. For more information on RSV, visit renown.org. Renown Urgent Care Renown Urgent Care está disponible para proporcionar asistencia médica los 7 días de la semana en 11 ubicaciones de todo el norte de Nevada, y brinda tratamiento para una amplia variedad de lesiones leves, enfermedades e inquietudes médicas que son urgentes, pero no suponen un riesgo para la vida. Si requiere atención médica en el mismo día, puede evitar los tiempos de espera prolongados y los altos precios de la sala de emergencias en 13 ubicaciones convenientes, incluidas Reno, Sparks, Carson City, USA Parkway, Fallon y Fernley. You can walk-in or book ahead online. Acerca de Renown Health Renown Health es una red de atención médica integrada de administración local y sin fines de lucro que brinda servicios al norte de Nevada, Lake Tahoe y el noreste de California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown tiene una larga trayectoria y un compromiso de larga data con la mejora de la atención y la salud de nuestra comunidad. Visite renown.org para obtener más información.

    Read More About Got a Cough, Runny Nose, Sore Throat and Fever? It Might Be RSV Virus

Número de resultados encontrados: 17
Use esta navegación adicional para ir a las páginas siguientes. Use las teclas de tabulación e Intro para navegar por el menú1 Página n.º 2 Navegar a la página siguiente Página 1 de 2
Saltee a 17 resultados encontrados. Página 1 de 2